Pietro Enea Lazzerini Selected Research

Sick Sinus Syndrome

1/2019

Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pietro Enea Lazzerini Research Topics

Disease

16	Inflammation (Inflammations) 01/2022 - 02/2005
10	COVID-19 11/2022 - 01/2020
9	Long QT Syndrome 09/2021 - 01/2016
7	Cardiac Arrhythmias (Arrythmia) 01/2022 - 01/2008
6	Torsades de Pointes (Torsade de Pointes) 01/2021 - 04/2016
6	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 08/2007
6	Hyperhomocysteinemia 05/2016 - 07/2003
5	Ischemic Stroke 01/2021 - 05/2016
5	Arthritis (Polyarthritis) 01/2019 - 10/2008
4	Infections 01/2022 - 11/2017
4	Atrioventricular Block 01/2022 - 02/2015
4	Heart Arrest (Cardiac Arrest) 01/2021 - 09/2017
4	Rheumatoid Arthritis 11/2017 - 08/2008
3	Channelopathies 01/2021 - 09/2017
3	Atrial Remodeling 01/2020 - 01/2017
3	Fibrosis (Cirrhosis) 12/2015 - 03/2012
3	Systemic Scleroderma (Systemic Sclerosis) 04/2015 - 03/2012
3	Connective Tissue Diseases (Connective Tissue Disease) 03/2012 - 04/2004
3	Congenital heart block 10/2011 - 01/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2011 - 11/2004
2	Stroke (Strokes) 01/2022 - 05/2016
2	Heart Diseases (Heart Disease) 09/2021 - 01/2018
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2019 - 10/2013
2	Tachycardia (Tachyarrhythmias) 09/2017 - 10/2008
2	Rheumatic Diseases (Rheumatism) 04/2011 - 08/2008
2	Heart Failure 02/2005 - 02/2003
2	Renal Insufficiency (Renal Failure) 11/2004 - 07/2003
1	Diarrhea 01/2022
1	Atrial Fibrillation 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Cortical Blindness (Anton Syndrome) 01/2022
1	Agnosia (Visual Agnosia) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022
1	Infarction (Infarctions) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Autoimmune Hepatitis 10/2021
1	Hypothyroidism 09/2021
1	Type 2 Diabetes Mellitus (MODY) 09/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Sick Sinus Syndrome 01/2019
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2019
1	Ventricular Tachycardia 01/2018
1	Necrosis 11/2017
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 09/2017
1	Left Ventricular Dysfunction 06/2017

Drug/Important Bio-Agent (IBA)

11	Interleukin-6 (Interleukin 6)IBA 11/2022 - 08/2008
10	CytokinesIBA 01/2022 - 02/2003
10	AntibodiesIBA 01/2021 - 04/2004
7	C-Reactive ProteinIBA 01/2022 - 06/2013
7	AutoantibodiesIBA 01/2021 - 05/2006
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 03/2007
5	HomocysteineIBA 05/2016 - 07/2003
4	Potassium Channels (Potassium Channel)IBA 01/2021 - 01/2016
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 01/2022
3	Pharmaceutical PreparationsIBA 09/2021 - 10/2008
3	Ion Channels (Ion Channel)IBA 01/2021 - 09/2017
3	Purinergic P1 Receptors (Adenosine Receptor)IBA 06/2017 - 02/2003
3	Proteins (Proteins, Gene)FDA Link 01/2010 - 07/2003
2	Anti-Arrhythmia AgentsIBA 01/2022 - 03/2015
2	Anti-Idiotypic AntibodiesIBA 01/2021 - 04/2016
2	Monoclonal AntibodiesIBA 01/2017 - 01/2016
2	Biological ProductsIBA 01/2017 - 12/2015
2	CannabinoidsIBA 09/2012 - 03/2012
2	Cysteine (L-Cysteine)FDA Link 11/2004 - 07/2003
2	cysteinylglycine (Cys-Gly)IBA 11/2004 - 07/2003
2	DisulfidesIBA 11/2004 - 07/2003
2	Sulfhydryl Compounds (Thiols)IBA 11/2004 - 07/2003
2	Glutathione (Reduced Glutathione)IBA 11/2004 - 07/2003
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2022
1	Ritonavir (Norvir)FDA Link 01/2022
1	Drug CombinationsIBA 01/2022
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2022
1	Lopinavir FDA Link 01/2022
1	Testosterone (Sustanon)FDA Link 01/2022
1	P-2 (P 2)IBA 01/2022
1	Connexin 43 (Connexin43)IBA 11/2021
1	VaccinesIBA 10/2021
1	Antirheumatic Agents (DMARD)IBA 01/2021
1	Ether (Diethyl Ether)IBA 01/2021
1	AntigensIBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	AndrogensIBA 01/2020
1	Calcium Channels (Calcium Channel)IBA 01/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	ConnexinsIBA 01/2019
1	CalciumIBA 01/2019
1	Interleukin-1 (Interleukin 1)IBA 11/2017
1	Lansoprazole (Prevacid)FDA LinkGeneric 11/2017
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 11/2017

Therapy/Procedure

9	Therapeutics 01/2022 - 03/2015
4	Heart Transplantation (Grafting, Heart) 05/2016 - 02/2003
2	Thrombectomy 01/2022 - 09/2017
2	Mechanical Thrombolysis 01/2022 - 01/2021
1	Drug Therapy (Chemotherapy) 01/2022
1	Personal Protective Equipment 01/2022
1	Off-Label Use 01/2022
1	Thrombolytic Therapy 09/2017